| 1 |
29854416 | Relapse Rate and MRI Activity in Young Adult Patients With Multiple Sclerosis: A Post Hoc Analysis of Phase 3 Fingolimod Trials. | 2018 Apr-Jun |
1 |
| 2 |
26111826 | Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study. | 2016 May |
2 |
| 3 |
24059944 | Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis. | 2013 Dec |
1 |